Old Web
English
Sign In
Acemap
>
authorDetail
>
Paul E. Genereux
Paul E. Genereux
Pfizer
Endocrinology
Internal medicine
Insulin
Englitazone
Glycogen phosphorylase
7
Papers
217
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
O-3: Skeletal muscle expression of a human GLUTI transgene results in improved glucose homeostasis and weight loss in obese, diabetic (dbldb) mice
2009
Experimental and Clinical Endocrinology & Diabetes
E. Michael Gibbs
William J. Zavadoski
Paul E. Genereux
Paul D McGill
Jay S. Lillquist
Garret J. Etgen
Ralph W. Stevenson
Scott C. McCoid
Show All
Source
Cite
Save
Citations (0)
Possibility of Distinct Insulin-Signaling Pathways Beyond Phosphatidylinositol 3-Kinase–Mediating Glucose Transport and Lipogenesis
1998
Diabetes
Ralph W. Stevenson
David K. Kreutter
Kim M. Andrews
Paul E. Genereux
E. M. Gibbs
Show All
Source
Cite
Save
Citations (17)
Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.
1998
Journal of Medicinal Chemistry
Dennis J. Hoover
Lefkowitz-Snow S
Burgess-Henry Jl
William H. Martin
Armento Sj
Ingrid A. Stock
R K McPherson
Paul E. Genereux
E. M. Gibbs
Judith L. Treadway
Show All
Source
Cite
Save
Citations (100)
The Antihyperglycemic Agent Englitazone Prevents the Defect in Glucose Transport in Rats Fed a High-Fat Diet
1996
Diabetes
Ralph W. Stevenson
R K McPherson
Lorna M. Persson
Paul E. Genereux
A. G. Swick
J. Spitzer
Herbst Jj
Kim M. Andrews
David K. Kreutter
E. M. Gibbs
Show All
Source
Cite
Save
Citations (21)
1